tiprankstipranks
Trending News
More News >
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market

Jubilant Pharmova Limited (JUBLPHARMA) Income Statement

Compare
2 Followers

Jubilant Pharmova Limited Income Statement

Last quarter (Q1 2026), Jubilant Pharmova Limited's total revenue was ₹19.01B, an increase of 9.76% from the same quarter last year. In Q1, Jubilant Pharmova Limited's net income was ₹1.03B. See Jubilant Pharmova Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 72.34B₹ 67.03B₹ 62.82B₹ 61.30B₹ 60.99B
Gross Profit
₹ 46.99B₹ 43.52B₹ 42.00B₹ 46.42B₹ 45.63B
Operating Expenses
₹ 23.43B₹ 22.87B₹ 22.15B₹ 20.74B₹ 19.44B
Depreciation and Amortization
₹ 2.44B₹ 2.70B₹ 2.71B₹ 2.26B₹ 3.23B
EBITDA
₹ 10.48B₹ 7.93B₹ 6.46B₹ 10.66B₹ 14.68B
Operating Income
₹ 23.56B₹ 20.64B₹ 19.85B₹ 25.68B₹ 26.19B
Other Income/Expenses
₹ -13.75B₹ -18.94B₹ -19.57B₹ -19.38B₹ -17.47B
Pretax Income
₹ 9.81B₹ 1.71B₹ 278.00M₹ 6.30B₹ 8.71B
Net Income
₹ 8.39B₹ 771.00M₹ -610.00M₹ 4.14B₹ 8.36B
Per Share Metrics
Basic EPS
₹ 52.98₹ 4.86₹ -3.83₹ 26.01₹ 36.05
Diluted EPS
₹ 52.85₹ 4.86₹ -3.83₹ 26.00₹ 36.05
Weighted Average Shares Outstanding
158.83M 158.64M 159.15M 159.21M 231.88M
Weighted Average Shares Outstanding (Diluted)
158.87M 158.86M 159.15M 159.17M 159.27M
Currency in INR

Jubilant Pharmova Limited Earnings and Revenue History